Empagliflozin
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5307 publications
Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.
Journal: American journal of therapeutics
Published: June 24, 2026
Which aldosterone antagonist? Choosing between sprionolactone and the novel drug finerenone
Journal: Nederlands tijdschrift voor geneeskunde
Published: June 15, 2026
GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.
Journal: Disease-a-month : DM
Published: June 12, 2026
Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space.
Journal: Journal of the American Heart Association
Published: June 09, 2026
Antidiabetes agents and risk of incident depression in 686,522 people with type 2 diabetes mellitus: A 20-year population-based cohort study.
Journal: Psychological medicine
Published: June 08, 2026
In vivo genotoxicity assessment of oral antidiabetic drugs in Drosophila melanogaster.
Journal: Journal of toxicology and environmental health. Part A
Published: June 07, 2026
Photochemical C-O Coupling of Chiral Alcohols with Aryl Halides by Nickel Catalysis.
Journal: Organic letters
Published: June 05, 2026
Determination of S-enantiomer in linagliptin by supercritical fluid chromatography-ultraviolet detection
Journal: Se pu = Chinese journal of chromatography
Published: June 05, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: June 05, 2026
Organ-Specific Efficacy of Postischemic Empagliflozin in Acute Stroke and Myocardial Infarction Using Preclinical Models.
Journal: Journal of the American Heart Association
Published: May 30, 2026
Last Updated: 06/30/2026